The North America Diagnostic Radiopharmaceutical is expanding rapidly due to the region's strong healthcare infrastructure, increasing prevalence of chronic diseases, and rising adoption of molecular imaging technologies. Countries such as the United States and Canada are investing heavily in nuclear medicine, research and development, and advanced diagnostic imaging solutions to enhance...